A. D. Beadell Investment Counsel, Inc. Astrazeneca PLC Transaction History
A. D. Beadell Investment Counsel, Inc.
- $123 Million
- Q4 2024
A detailed history of A. D. Beadell Investment Counsel, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, A. D. Beadell Investment Counsel, Inc. holds 13,385 shares of AZN stock, worth $924,368. This represents 0.71% of its overall portfolio holdings.
Number of Shares
13,385Holding current value
$924,368% of portfolio
0.71%Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,340Shares Held
476MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.34 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.9 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.57 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.54 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.32 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $214B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...